HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...

In today's D.C. Diagnosis newsletter, layoffs hit the National Academies, and a look at what's already been lost from firings ...

A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.

Last week, I was flipping through the newly filed financial documents of AdventHealth, and the numbers hit me like an ...

Digital physical therapy company Hinge Health went public last week, raising $437 million and ending an IPO drought for ...

As a public health official, Jay K. Varma has handled putative anthrax attacks. He says an AI-simulated bioterror attack ...

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

Harvard's Scott Delaney helped build a database of NIH grant terminations that is being used in litigation against the Trump ...

Earlier gatherings focused on gaining public acceptance for what scientists want to do with CRISPR. This meeting flipped that ...

The National Academies of Sciences, Engineering, and Medicine is preparing for a major reorganization as it tries to reduce ...

The human organism is far too complex and unpredictable to program like a computer and optimize for longevity.